Security
EUDA Health Holdings Limited Ordinary Shares · EUDA
EUDANASDAQCommon stockCurrentCIK 1847846Updated Oct 14, 2026
Name history
8i Acquisition 2 Corp. · through Nov 17, 2022
EUDA price & chart
Loading TradingView…
NASDAQ:EUDA on TradingView ↗In the news
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2021 | Q2 2025 | Q2 2024 | Q2 2021 | Q1 2023 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| AssetsUSD | — | 2,122,451Source | 2,027,942Source | 428,920Source | 25,478,778Source | 1,716,562Source | 1,697,810Source | 1,310,508Source | 25,629,040Source |
| Property, Plant and Equipment, NetUSD | — | 106,587Source | 9,960Source | — | 27,892Source | 137,294Source | 87,712Source | 6,732Source | 31,628Source |
| GoodwillUSD | — | — | — | — | — | — | 0Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 260,370Source | 350,847Source | — | — | 161,434Source | 337,295Source | — | — |
| Current assets: | |||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | 376,206Source | — | 837,292Source | — | — | 189,005Source | 143,024Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 426,688Source | 176,988Source | — | 1,585,378Source | 242,613Source | 146,174Source | 237,474Source | 1,851,503Source |
| Inventory, NetUSD | — | 116,845Source | — | — | — | 2,844Source | 128,977Source | — | — |
| Assets, CurrentUSD | — | 1,306,436Source | 1,056,359Source | 428,920Source | 24,802,102Source | 1,039,366Source | 762,876Source | 723,441Source | 25,026,478Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | 514,780Source | 207,358Source | — | 198,123Source | 357,175Source | 226,027Source | 192,412Source | 222,633Source |
| Operating Lease, Right-of-Use AssetUSD | — | 194,315Source | 252,433Source | — | 180,480Source | 177,030Source | 202,980Source | 168,278Source | 76,528Source |
| LIABILITIES AND EQUITY | |||||||||
| LiabilitiesUSD | — | 5,848,771Source | 8,039,452Source | 399,797Source | 31,417,343Source | 5,984,084Source | 4,269,878Source | 8,792,444Source | 29,136,071Source |
| Stockholders’ equity: | |||||||||
| Common Stock, Value, IssuedUSD | — | 47,829,228Source | 45,693,774Source | — | 21,308,969Source | 48,829,228Source | 47,806,899Source | 27,430,187Source | 21,308,969Source |
| Retained Earnings (Accumulated Deficit)USD | — | -51,304,427Source | -51,571,099Source | -8,377Source | -27,118,434Source | -52,873,188Source | -50,100,426Source | -34,743,270Source | -24,703,789Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | -234,366Source | -145,852Source | — | -144,108Source | -210,985Source | -259,532Source | -185,468Source | -125,689Source |
| Stockholders' Equity Attributable to ParentUSD | -16,464Source | -3,709,565Source | -6,023,177Source | 29,123Source | -5,953,573Source | -4,254,945Source | -2,553,059Source | -7,498,551Source | -3,520,509Source |
| Liabilities and EquityUSD | — | 2,122,451Source | 2,027,942Source | 428,920Source | 25,478,778Source | 1,716,562Source | 1,697,810Source | 1,310,508Source | 25,629,040Source |
| Current liabilities: | |||||||||
| Liabilities, CurrentUSD | — | 5,707,291Source | 7,884,030Source | — | 31,332,300Source | 5,835,533Source | 4,141,374Source | 8,717,333Source | 29,121,056Source |
| Operating Lease, Liability, CurrentUSD | — | 132,368Source | 202,321Source | — | 108,942Source | 126,973Source | 174,757Source | 121,776Source | 79,959Source |
| Accounts Payable, CurrentUSD | — | 316,511Source | 37,904Source | — | 1,836,497Source | 14,147Source | 25,886Source | 1,289Source | 1,635,483Source |
| Operating Lease, Liability, NoncurrentUSD | — | 61,947Source | 50,112Source | — | 71,720Source | 50,057Source | 28,222Source | 46,501Source | — |
| Deferred Income Tax Liabilities, NetUSD | — | 58,699Source | 80,099Source | — | — | 81,079Source | 76,700Source | — | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | -16,755Source | 11,667Source | — | 15,008Source | -12,577Source | -19,009Source | 16,615Source | 13,478Source |
| Additional Financial Items | |||||||||
| Accrued Liabilities, CurrentUSD | — | 1,283,180Source | 968,062Source | 3,640Source | 1,650,170Source | 1,351,245Source | 1,180,519Source | 823,345Source | 671,743Source |
| Additional Paid in Capital | — | — | — | —Source | — | — | — | — | — |
cash flow · annual statements
| Line item | Q3 2021 | Q2 2024 | Q2 2023 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -2,413,238Source | 224,994Source | -2,767,710Source | -15,391,443Source | -10,036,104Source | -24,949,246Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
| Depreciation and amortization | — | — | — | — | — | —Source | —Source | — | — |
| Changes in operating assets and liabilities: | |||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | -244,693Source | 264,618Source | 85,986Source | -85,220Source | 33,966Source | 174,824Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | -45,428Source | 126,274Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | 187,415Source | -2,304Source | -12,949Source | 15,992Source | 1,269Source | 1,268,701Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | -5,022Source | 4,379Source | -4,379Source | — | -48,228Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | -469,908Source | -252,196Source | -2,426,535Source | -2,034,727Source | -2,917,895Source | -1,526,828Source |
| Cash flows from investing activities: | |||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | -29,326Source | -104,450Source | -147,766Source | — | -268,206Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | 77,264Source | 96,762Source | — | 18,137Source |
| Cash flows from financing activities: | |||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | 525,328Source | 331,439Source | 2,550,031Source | 2,324,199Source | 2,352,495Source | 2,488,947Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | 52,807Source | 47,250Source | 107,540Source | 40,051Source | -586,931Source | 594,489Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 400,000Source | — | 800,000Source | — | 345,144Source | — | 200,000Source | 784,485Source |
| Supplemental disclosure of cash flow information: | |||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | 6,090Source | 24,304Source | 5,996Source | 55,382Source | 17,520Source | 19,588Source |
| Income Taxes Paid, NetUSD | — | — | — | 9,353Source | 33,299Source | 32,156Source | 11,627Source | 42,900Source | 156,339Source |
| Additional Financial Items | |||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | 29,544Source | 156,660Source | 20,172Source | — | 115,907Source |
| DepreciationUSD | — | — | — | 3,981Source | 6,950Source | 38,549Source | 22,111Source | 4,886Source | 23,347Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | — | — | — | -11,218Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | -448,000Source | -645,612Source | — |
| General and Administrative ExpenseUSD | — | — | — | 1,975,607Source | 824,896Source | 4,149,280Source | 3,211,859Source | 4,269,567Source | 7,153,248Source |
| GoodwillUSD | — | — | — | — | — | — | 0Source | — | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 971,229Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 167,787Source |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | — | 0Source | 0Source | 37,480Source | 14,755,560Source | — | 167,787Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | -2,767,710Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -612,426Source | — | -2,767,710Source | -17,637,783Source | -8,434,781Source | 5,414,370Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | 2,246,340Source | -1,601,323Source | — |
| Income Tax Expense (Benefit)USD | — | — | — | 985Source | 5,823Source | 41,935Source | -4,379Source | — | 17,422Source |
| InterestExpenseNonoperatingUSD | — | — | — | — | — | 228,624Source | — | — | — |
| Inventory Write-downUSD | — | — | — | — | — | 86,656Source | 0Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -45,587Source | — | — | -2,414,645Source | 222,585Source | -2,772,762Source | -15,357,156Source | -10,039,481Source | -24,884,122Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | 1,407Source | 2,409Source | 5,052Source | -34,287Source | 3,377Source | -65,124Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -2,414,465Source | 222,585Source | — | -17,603,496Source | -8,438,158Source | -24,884,122Source |
| Nonoperating Income (Expense)USD | — | — | — | -435,473Source | 155,505Source | -247,783Source | -307,031Source | -4,473,727Source | -12,874,053Source |
| Operating ExpensesUSD | — | — | — | 2,380,378Source | 1,195,934Source | 5,470,791Source | 18,097,286Source | 4,803,129Source | 15,411,967Source |
| Other Nonoperating Income (Expense)USD | — | — | — | 108,396Source | 145,537Source | 5,841Source | 185,859Source | 134,584Source | 127,477Source |
| Proceeds from Contributed CapitalUSD | — | — | — | — | — | — | — | — | 600,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 500,000Source |
income statement · annual statements
| Line item | Q3 2021 | Q2 2023 | Q1 2023 | Q1 2022 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 1,698,734Source | 2,666,863Source | 6,820,264Source | 4,011,005Source | 3,706,458Source | 9,840,709Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source |
| Operating Income (Loss)USD | — | — | -1,976,780Source | 75,312Source | -2,477,992Source | -17,335,131Source | -3,961,054Source | -12,057,771Source |
| Other Nonoperating Income (Expense)USD | — | — | 108,396Source | 145,537Source | 5,841Source | 185,859Source | 134,584Source | 127,477Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -2,412,253Source | 230,817Source | -2,725,775Source | -17,642,162Source | -8,434,781Source | -24,931,824Source |
| Income Tax Expense (Benefit)USD | — | — | 985Source | 5,823Source | 41,935Source | -4,379Source | — | 17,422Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 1,407Source | 2,409Source | 5,052Source | -34,287Source | 3,377Source | -65,124Source |
| Net Income (Loss) Attributable to ParentUSD | -45,587Source | — | -2,414,645Source | 222,585Source | -2,772,762Source | -15,357,156Source | -10,039,481Source | -24,884,122Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.12Source | 0.02Source | -1.48Source | -0.47Source | -0.44Source | -2.07Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.12Source | 0.02Source | -1.48Source | -0.47Source | -0.44Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 20,191,770Source | 9,253,333Source | 1,867,716Source | 32,459,921Source | 22,900,631Source | 12,029,656Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 20,191,770Source | 9,253,333Source | 1,867,716Source | 32,459,921Source | 22,900,631Source | 12,029,656Source |
| Interest Expense (non-operating)USD | — | — | — | — | 228,624Source | — | — | — |
| Additional Financial Items | ||||||||
| Amortization of Intangible AssetsUSD | — | — | — | 29,544Source | 156,660Source | 20,172Source | — | 115,907Source |
| Current Income Tax Expense (Benefit)USD | — | — | 985Source | 10,845Source | 37,556Source | — | — | 65,650Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | 195,209Source | 173,217Source | — | — |
| General and Administrative ExpenseUSD | — | — | 1,975,607Source | 824,896Source | 4,149,280Source | 3,211,859Source | 4,269,567Source | 7,153,248Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | 971,229Source |
| Gross ProfitUSD | — | — | 403,598Source | 1,271,246Source | 2,992,799Source | 762,155Source | 842,075Source | 3,354,196Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | -2,767,710Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | -612,426Source | 231,151Source | — | — | -203,411Source | -5,400,034Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -612,426Source | — | -2,767,710Source | -17,637,783Source | -8,434,781Source | 5,414,370Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | -1.48Source | -0.54Source | -0.37Source | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | — | -1.48Source | -0.54Source | -0.37Source | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | 2,246,340Source | -1,601,323Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -2,414,465Source | 222,585Source | — | -17,603,496Source | -8,438,158Source | -24,884,122Source |
| Nonoperating Income (Expense)USD | — | — | -435,473Source | 155,505Source | -247,783Source | -307,031Source | -4,473,727Source | -12,874,053Source |
| Operating ExpensesUSD | — | — | 2,380,378Source | 1,195,934Source | 5,470,791Source | 18,097,286Source | 4,803,129Source | 15,411,967Source |
| Research and Development ExpenseUSD | — | — | — | 2,946Source | 249Source | — | — | 17,209Source |
| Selling and Marketing ExpenseUSD | — | — | 404,771Source | 368,092Source | 1,283,782Source | 129,867Source | 533,562Source | 1,902,865Source |
Offerings
Registration 333-296224
Filing attachments
ex99-1.htm · 6-K · 2026-10-13
Exhibit 99.1 EUDA Health Holdings Limited (incorporated under the laws of the British Virgin Islands) (NASDAQ: EUDA, EUDAW) NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN THAT an extraordinary general meeting of shareholders (the “ EGM ”) of EUDA Health Holdings Limited (the “ Company ”) will be held on October 30, 2026, at 9:00 a.m., Eastern U.S. Time. The EGM will be held virtually at https://edge.media-server.com/mmc/p/bxcczqfc. The purpose of the EGM is …
Read attachment ↗ex99-2.htm · 6-K · 2026-10-13
Exhibit 99.2 EUDA HEALTH HOLDINGS LIMITED 60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979 FOR THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF EUDA HEALTH HOLDINGS LIMITED THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned, revoking any previous proxies relating to the EGM (as defined below), hereby acknowledges receipt of the notice and proxy statement, dated October 13, 2026, (the “ Proxy Statement ”) in connection with the extraordinary genera…
Read attachment ↗ex99-1.htm · 6-K · 2026-09-29
Exhibit 99.1 EUDA HEALTH HOLDINGS LIMITED AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS June 30, December 31, 2026 2025 ─────────────────────────────────────────────────────────────────────────────…
Read attachment ↗ex99-2.htm · 6-K · 2026-09-29
Exhibit 99.2 OPERATING AND FINANCIAL REVIEW AND PROSPECTS IN CONNECTION WITH THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025 In this report, as used herein, and unless the context suggests otherwise, the terms “EUDA,” “Company,” “we,” “us” or “ours” refer to the combined business of Euda Health Holdings Limited and its subsidiaries and other consolidated entities. References to “dollar” and “$” are to U.S. dollars, the lawful c…
Read attachment ↗ex99-1.htm · 6-K · 2026-08-26
Exhibit 99.1 EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore SINGAPORE, AUGUST, Aug. 26, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based distributor of third-party wellness and non-invasive healthcare products and services in Singapore, Malaysia and China, as well as property management services in Singapore, today announced that its subsidiary, Melana International Pte. Ltd. (“Melana”), was recogni…
Read attachment ↗ex99-1.htm · 6-K · 2026-07-31
Exhibit 99.1 EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) - EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today provided important additional details of the i…
Read attachment ↗